215 related articles for article (PubMed ID: 29463573)
1. Mutant p53 controls tumor metabolism and metastasis by regulating PGC-1α.
Basu S; Gnanapradeepan K; Barnoud T; Kung CP; Tavecchio M; Scott J; Watters A; Chen Q; Kossenkov AV; Murphy ME
Genes Dev; 2018 Feb; 32(3-4):230-243. PubMed ID: 29463573
[TBL] [Abstract][Full Text] [Related]
2. PGC-1α mediates mitochondrial biogenesis and oxidative phosphorylation in cancer cells to promote metastasis.
LeBleu VS; O'Connell JT; Gonzalez Herrera KN; Wikman H; Pantel K; Haigis MC; de Carvalho FM; Damascena A; Domingos Chinen LT; Rocha RM; Asara JM; Kalluri R
Nat Cell Biol; 2014 Oct; 16(10):992-1003, 1-15. PubMed ID: 25241037
[TBL] [Abstract][Full Text] [Related]
3. PGC-1α Promotes Breast Cancer Metastasis and Confers Bioenergetic Flexibility against Metabolic Drugs.
Andrzejewski S; Klimcakova E; Johnson RM; Tabariès S; Annis MG; McGuirk S; Northey JJ; Chénard V; Sriram U; Papadopoli DJ; Siegel PM; St-Pierre J
Cell Metab; 2017 Nov; 26(5):778-787.e5. PubMed ID: 28988825
[TBL] [Abstract][Full Text] [Related]
4. Mutant p53 blocks SESN1/AMPK/PGC-1α/UCP2 axis increasing mitochondrial O
Cordani M; Butera G; Dando I; Torrens-Mas M; Butturini E; Pacchiana R; Oppici E; Cavallini C; Gasperini S; Tamassia N; Nadal-Serrano M; Coan M; Rossi D; Gaidano G; Caraglia M; Mariotto S; Spizzo R; Roca P; Oliver J; Scupoli MT; Donadelli M
Br J Cancer; 2018 Oct; 119(8):994-1008. PubMed ID: 30318520
[TBL] [Abstract][Full Text] [Related]
5. SNPing away at mutant p53 activities.
Ortiz GJ; Lozano G
Genes Dev; 2018 Feb; 32(3-4):195-196. PubMed ID: 29491132
[TBL] [Abstract][Full Text] [Related]
6. [Effect of peroxisome proliferator-activated receptor-γ coactivator-1α on metastasis and anoikis resistance in colorectal cancer].
Lu XF; Xia XF; Chen G
Zhonghua Zhong Liu Za Zhi; 2016 Jul; 38(7):499-503. PubMed ID: 27531262
[TBL] [Abstract][Full Text] [Related]
7. The codon 72 polymorphism of p53 influences cell fate following nutrient deprivation.
Kung CP; Liu Q; Murphy ME
Cancer Biol Ther; 2017 Jul; 18(7):484-491. PubMed ID: 28475405
[TBL] [Abstract][Full Text] [Related]
8. Interplay between ShcA Signaling and PGC-1α Triggers Targetable Metabolic Vulnerabilities in Breast Cancer.
Im YK; Najyb O; Gravel SP; McGuirk S; Ahn R; Avizonis DZ; Chénard V; Sabourin V; Hudson J; Pawson T; Topisirovic I; Pollak M; St-Pierre J; Ursini-Siegel J
Cancer Res; 2018 Sep; 78(17):4826-4838. PubMed ID: 29930100
[TBL] [Abstract][Full Text] [Related]
9. Hypoxia-induced PGC-1α Regulates Mitochondrial Function and Tumorigenesis of Colorectal Cancer Cells.
Yun CW; Lee JH; Lee SH
Anticancer Res; 2019 Sep; 39(9):4865-4876. PubMed ID: 31519589
[TBL] [Abstract][Full Text] [Related]
10. Metformin induces microRNA-34a to downregulate the Sirt1/Pgc-1α/Nrf2 pathway, leading to increased susceptibility of wild-type p53 cancer cells to oxidative stress and therapeutic agents.
Do MT; Kim HG; Choi JH; Jeong HG
Free Radic Biol Med; 2014 Sep; 74():21-34. PubMed ID: 24970682
[TBL] [Abstract][Full Text] [Related]
11. PGC-1α promotes the growth of ErbB2/Neu-induced mammary tumors by regulating nutrient supply.
Klimcakova E; Chénard V; McGuirk S; Germain D; Avizonis D; Muller WJ; St-Pierre J
Cancer Res; 2012 Mar; 72(6):1538-46. PubMed ID: 22266114
[TBL] [Abstract][Full Text] [Related]
12. Gain-of-function of mutant p53: mutant p53 enhances cancer progression by inhibiting KLF17 expression in invasive breast carcinoma cells.
Ali A; Shah AS; Ahmad A
Cancer Lett; 2014 Nov; 354(1):87-96. PubMed ID: 25111898
[TBL] [Abstract][Full Text] [Related]
13. Peroxisome proliferator-activated receptor-γ coactivator-1α mediates neuroprotection against excitotoxic brain injury in transgenic mice: role of mitochondria and X-linked inhibitor of apoptosis protein.
Mäkelä J; Mudò G; Pham DD; Di Liberto V; Eriksson O; Louhivuori L; Bruelle C; Soliymani R; Baumann M; Korhonen L; Lalowski M; Belluardo N; Lindholm D
Eur J Neurosci; 2016 Mar; 43(5):626-39. PubMed ID: 26741810
[TBL] [Abstract][Full Text] [Related]
14. Targeting PSAT1 to mitigate metastasis in tumors with p53-72Pro variant.
Jiang J; Chen HN; Jin P; Zhou L; Peng L; Huang Z; Qin S; Li B; Ming H; Luo M; Xie N; Gao W; Nice EC; Yu Q; Huang C
Signal Transduct Target Ther; 2023 Feb; 8(1):65. PubMed ID: 36788227
[TBL] [Abstract][Full Text] [Related]
15. KDM3A Senses Oxygen Availability to Regulate PGC-1α-Mediated Mitochondrial Biogenesis.
Qian X; Li X; Shi Z; Bai X; Xia Y; Zheng Y; Xu D; Chen F; You Y; Fang J; Hu Z; Zhou Q; Lu Z
Mol Cell; 2019 Dec; 76(6):885-895.e7. PubMed ID: 31629659
[TBL] [Abstract][Full Text] [Related]
16. Peroxisome proliferator-activated receptor γ coactivator-1α is a predictor of lymph node metastasis and poor prognosis in human colorectal cancer.
Yun SH; Roh MS; Jeong JS; Park JI
Ann Diagn Pathol; 2018 Apr; 33():11-16. PubMed ID: 29566941
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of plasma levels of HIF-1a and PGC-1a in breast cancer.
Cai FF; Xu C; Pan X; Cai L; Lin XY; Chen S; Biskup E
Oncotarget; 2016 Nov; 7(47):77793-77806. PubMed ID: 27780920
[TBL] [Abstract][Full Text] [Related]
18. PGC-1α, glucose metabolism and type 2 diabetes mellitus.
Wu H; Deng X; Shi Y; Su Y; Wei J; Duan H
J Endocrinol; 2016 Jun; 229(3):R99-R115. PubMed ID: 27094040
[TBL] [Abstract][Full Text] [Related]
19. Fibroblast growth factor 21 increases hepatic oxidative capacity but not physical activity or energy expenditure in hepatic peroxisome proliferator-activated receptor γ coactivator-1α-deficient mice.
Fletcher JA; Linden MA; Sheldon RD; Meers GM; Morris EM; Butterfield A; Perfield JW; Rector RS; Thyfault JP
Exp Physiol; 2018 Mar; 103(3):408-418. PubMed ID: 29215172
[TBL] [Abstract][Full Text] [Related]
20. Skeletal Muscle-Specific Overexpression of PGC-1α Induces Fiber-Type Conversion through Enhanced Mitochondrial Respiration and Fatty Acid Oxidation in Mice and Pigs.
Zhang L; Zhou Y; Wu W; Hou L; Chen H; Zuo B; Xiong Y; Yang J
Int J Biol Sci; 2017; 13(9):1152-1162. PubMed ID: 29104506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
